Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 302 Magnetic Resonance Spectroscopy 261 pembrolizumab 249 Carboplatin 184 Cyclophosphamide 175 Biopsy 167 Cisplatin 157 Gemcitabine 134 Paclitaxel 130 Bevacizumab 123 fludarabine 115 Nivolumab 108 Radiotherapy 107 Oxaliplatin 88 Docetaxel 87 Fluorouracil 85 Capecitabine 83 venetoclax 78 Dexamethasone 76 Pemetrexed 72 Rituximab 69 Leucovorin 69 Drug Therapy 69 atezolizumab 67 durvalumab 66 Radiosurgery 65 Blood Specimen Collection 64 Doxorubicin 63 Standard of Care 62 Radiation 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sulfonylurea Compounds × 90 days × Clear all

NCT05663515 2026-06-02

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡